Skip to main content

Technologies

20 results found
Food / Agriculture Pharmaceuticals / Nutraceuticals Physics
Technologies
ID: 2019-015 Recombinant human Gal-1 treatment improves membrane repair capacity, increases myogenic markers and decreases inflammation in dysferlin deficient myotubes, providing novel evidence regarding how Gal-1 favorably improves muscle function in LGMD2B.
Technologies
ID: 2019-057 Production of D-Allulose (D-psicose) from Bovine Lactose or Milk/Whey Permeate